Dual role of cyclooxygenase-2 during tissue repair induced by low level laser therapy: An intriguing issue

Journal of Cosmetic and Laser Therapy

Volumn 87, Issue 4, 2012, Pages 184-188

  Ribeiro, Daniel A ^a   Paiotti, Ana Paula R ^a   Medalha, Carla C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cyclooxygenase 2; Low level laser therapy; Tissue repair

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CARRAGEENAN; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 2; LINOLENIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; VALINE;

BONE REMODELING; CELL ACTIVATION; CELL CULTURE; CRYSTAL STRUCTURE; FIBROBLAST; HEALTH STATUS; HUMAN; LOW LEVEL LASER THERAPY; LUNG LAVAGE; NONHUMAN; ORAL MUCOSITIS; OSTEOPOROSIS; POSTOPERATIVE EDEMA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKELETAL MUSCLE; TISSUE REPAIR; TOOTH EXTRACTION; X RAY CRYSTALLOGRAPHY;

EID: 84864067122     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.3109/14764172.2012.685479     Document Type: Review

References (37)

1. DeWitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA. 1988;85:1412-1416.
2. Merlie JP, Fagan D, Mudd J, Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxidase synthase (cyclooxygenase). J Biol Chem. 1988;263:3550-3553.
3. Yokoyama C, Takai T, Tanabe T. Primary structure of sheep prostaglandin endoperoxidase synthase deduced from cDNA sequence. FEBS Lett. 1988;2313:47-51.
4. Bakhle YS, Botting RM. Cyclooxygenase-2 and its regulation in Inflammation. Mediat Inflamm. 1988;5:305-323.
5. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta. 1996;1299:125-140.
6. Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol. 1996; 3:927-933.
7. Jouzeau JY, Terlain B, Abid A, Nédélec E, Netter P. Cyclooxygenase isoenzymes. How recent fi ndings affect thinking about nonsteroidal anti-Inflammatory drugs. Drugs. 1997;53: 563-582.
8. Mancini JA, Vickers PJ, O'Neill GP, Boily C, Falgueyret JP, Riendeau D. Mutation of serine-516 in human prostaglandin G/H synthase-2 to methionine or aspirin acetylation of this residue stimulates 15-R-HETE synthesis. FEBS Lett. 1994;34:233-237.
9. Picot D, Loll PJ, Garavito RM. The X-Ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 1994;367:243-249.
10. Lecomte M, Laneuville O, Ji C, DeWitt DL, Smith WL. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J Biol Chem. 1994;269: 13207-13215.
11. Botting RM. Vane' s discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology. Pharmacol Rep. 2010;62:518-525.
12. Griswold DE, Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2) rationale for selective inhibition and progress to date. Med Res Rev. 1996;16:181-206.
13. Wong E, Bayly C, Waterman HL, Riendeau D, Mancini JA. Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2 selective inhibitors by a double His513 to Arg and Ile523 to Val mutation. J Biol Chem 1997;272: 9280-9286.
14. Gierse JK, McDonald JJ, Hauser SD, Rangwala SH, Koboldt CM, Seibert K. A single amino acid difference between cyclooxygenase-1 and -2 reverses the selectivity of COX-2 specifi c inhibitors. J Biol Chem. 1996;271: 15810-15814.
15. Guo Q, Wang L, Ruan K, et al. Role of Val509 in time-Dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-Selective agents. J Biol Chem. 1995;271:19134-19139.
16. Mancini JA, Vickers PJ, O'Neill GP, Boily C, Falgueyret JP, Riendeau D . Arginini 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-Inflammatory drugs containing a carboxylic acid moiety. J Biol Chem. 1995;270:29372-29377.
17. Bhattacharyya DK, Lecomte M, Rieke CJ, Garavito M, Smith WL. Involvement of arginine 120, glutamate 524 and tyrosine 355 in the binding of arachidonate and 2- phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1. J Biol Chem. 1996;2712:179-184.
18. Ren Y, Loose-Nitchell DS, Kulmacz RJ. Prostaglandin H synthase-1 evaluation of C-Terminus function. Arch Biochem Biophys. 1995;316:751-757.
19. Ren Y, Walker C, Loose-Nitchell DS, Deng J, Ruan KH, Kulmacz RJ. Topology of prostaglandin H synthase-1 in the endoplasmic reticulum membrane. Arch Biochem Biophys. 1995;323:205-214.
20. Hudson N, Balsitis M, Everitt S, Hawkey CJ. Enhanced gastric leukotriene B4 synthesis in patients taking nonsteroidal anti-Inflammatory drugs. Gut. 1993;34:742-747.
21. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiInflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA. 1993;90:11693-11697.
22. Renno AC, Iwama AM, Shima P, Fernandes KR, Carvalho JG, de Oliveira P, Ribeiro DA. Effect of low level laser therapy (660 nm) on the healing of second degree skin burns in rats. J Cosmet Laser Ther. 2011;13:237-242.
23. Santuzzi CH, Buss HF, Pedrosa DF, Freire MO, Nogueira BV, Gon ç alves WL. Combined use of low level laser therapy and cyclooxygenase-2 selective inhibition on skin incisional wound reepithelialization in mice a preclinical study. Ann Bras Dermatol. 2011;86:278-283 [in Portuguese].
24. Renn óAC, Toma RL, Feitosa SM, Fernandes K, Bossini PS, de Oliveira P, Parizotto N, Ribeiro DA. Comparative effects of low-Intensity pulsed ultrasound and low-Level laser therapy on injured skeletal muscle. Photomed Laser Surg. 2011;29: 5-10.
25. de Almeida P, Lopes-Nartins R Á , Tomazoni SS, Silva JA Jr, de Carvalho Pde T, Bjordal JM, Leal Junior EC. Low-Level laser therapy improves skeletal muscle performance, decreases skeletal muscle damage and modulates mRNA expression of COX-1 and COX-2 in a dose-Dependent manner. Photochem Photobiol. 2011;87:1159-1163.
26. Mozzati M, Martinasso G, Cocero N, Pol R, Maggiora M, Muzio G, Canuto RA. Infl uence of superpulsed laser therapy on healing processes following tooth extraction. Photomed Laser Surg. 2011;29:565-571.
27. Pallotta RC, Bjordal JM, Frigo L, Leal Junior EC, Teixeira S, Marcos RL, Ramos L, Messias Fde M, Lopes-Nartins RA. Infrared (810-nm) low-Level laser therapy on rat experimental knee Inflammation. Laser Med Sci. 2012;27:71-78.
28. Pires D, Xavier M, Ara újo T, Silva JA Jr, Aimbire F, Albertini R. Low-Level laser therapy (LLLT, 780 nm) acts differently on mRNA expression of anti- and pro-Inflammatory mediators in an experimental model of collagenase-Induced tendinitis in rat. Lasers Med Sci. 2011;26:85-94.
29. Albertini R, Aimbire F, Villaverde AB, Silva JA Jr, Costa MS. COX-2 mRNA expression decreases in the subplantar muscle of rat paw subjected to carrageenan-Induced Inflammation after low level laser therapy. Inflamm Res. 2007;56: 228-229.
30. Lim W, Lee S, Kim I, Chung M, Kim M, Lim H, Park J, Kim O, Choi H. The anti-Inflammatory mechanism of 635 nm light-Emitting-Diode irradiation compared with existing COX inhibitors. Lasers Surg Med. 2007;39:614-621.
31. Pourzarandian A, Watanabe H, Ruwanpura SM, Aoki A, Noguchi K, Ishikawa I. ErYAG laser irradiation increases prostaglandin E production via the induction of cyclooxygenase- 2 mRNA in human gingival fi broblasts. J Periodontal Res. 2005;40:182-186.
32. Mayahara K, Yamaguchi A, Sakaguchi M, Igarashi Y, Shimizu N. Effect of Ga-Al-As laser irradiation on COX-2 and cPLA2- alpha expression in compressed human periodontal ligament cells. Lasers Surg Med. 2010;42:489-493.
33. Matsumoto MA, Ferino RV, Monteleone GF, Ribeiro DA. Low-Level laser therapy modulates cyclo-Oxygenase-2 expression during bone repair in rats. Lasers Med Sci. 2009;24: 195-201.
34. Bossini PS, RennóAC, Ribeiro DA, Fangel R, Peitl O, Zanotto ED, Parizotto NA. Biosilicate ® and low-Level laser therapy improve bone repair in osteoporotic rats. J Tissue Eng Regen Med. 2011;5:229-237.
35. Ribeiro DA, Matsumoto MA. Low-Level laser therapy improves bone repair in rats treated with anti-Inflammatory drugs. J Oral Rehabil. 2008;35:925-933.
36. Lopes NN, Plapler H, Chavantes MC, Lalla RV, Yoshimura EM, Alves MT. Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-Fl uorouracil-Induced oral mucositis in hamsters evaluation of two low-Intensity laser protocols. Support Care Cancer. 2009;17:1409-1415.
37. Aimbire F, Albertine R, de Magalhães RG, Lopes-Nartins RA, Castro-Faria-Neto HC, Z ângaro RA, Chavantes MC, Pacheco MT. Effect of LLLT Ga-Al-As (685 nm) on LPSinduced Inflammation of the airway and lung in the rat. Lasers Med Sci. 2005;20:11-20.